About Index Trending news
Analyze
Pricing
Vanda Pharmaceuticals

Vanda Pharmaceuticals

Work at Vanda Pharmaceuticals? Add yourself to this profile

Vanda Pharmaceuticals

Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development and commercialization of products for the
Edit Profile
More info

Elsewhere

Also headquartered in Washington, D.C.

The FCC The FCC Washington Post Washington Post The FAA The FAA Create Create Barack Obama Barack Obama NPR NPR World Bank World Bank Revolution Revolution IRS IRS Vox Media Vox Media

Companies in the same industry

TriVascular TriVascular Aratana Therapeutics Aratana Therapeutics Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical Adient Medical, Inc. Adient Medical, Inc. Tricida, Inc. Tricida, Inc. C-SATS, Inc. C-SATS, Inc. Elysium Health Elysium Health Semma Therapeutics Semma Therapeutics TRACON Pharmaceuticals TRACON Pharmaceuticals Creative Bioarray Creative Bioarray

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1
Add info
Latest funding
Post-IPO equity
$54,000,000
Employees

Unknown size

Locations
HQ
Washington, D.C., United States
Headquarters
The Motley Fool

Meet The Pill That Might Cure Your Jet Lag --

Health Stock markets
Vanda Pharmaceuticals
Vanda Pharmaceuticals
The Motley Fool

Why Vanda Pharmaceuticals' Shares Are Retreating Today --

Technology Stock markets
Vanda Pharmaceuticals
Vanda Pharmaceuticals